Aktis Oncology Inc
AKTSHealthcare|Biotechnology|USA
$27.88
-0.54 (-1.90%)
Tangible Book
$9.16
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (8)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Czibere Akos | Chief Medical Officer | 2026-07-08 | SELL | 50,000 | $27.77 | $1388.5K |
| Ron-Bigger Shulamit | COO | 2026-07-08 | SELL | 50,000 | $27.75 | $1387.5K |
| Kim Helen Susan | Director, 10% Owner | 2026-01-12 | BUY | 835,000 | $18 | $15030K |
| EcoR1 Capital, LLC | Director | 2026-01-12 | BUY | 2,222,222 | $18 | $40000K |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | 2026-01-12 | BUY | 1,112,777 | $18 | $20030K |
| GADICKE ANSBERT | 10% Owner | 2026-01-12 | BUY | 1,112,777 | $18 | $20030K |
| Vida Ventures II, LLC | 10% Owner | 2026-01-12 | BUY | 835,000 | $18 | $15030K |
| Foley Todd | Director, 10% Owner | 2026-01-12 | BUY | 232,870 | $18 | $4191.7K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked